Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Diagnostic Approach to The Patients with Suspected Primary Immunodeficiency.

Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A.

Endocr Metab Immune Disord Drug Targets. 2019 Aug 28. doi: 10.2174/1871530319666190828125316. [Epub ahead of print]

PMID:
31456526
2.

Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy.

Saberi S, Arjmand R, Khamesipour A, Nilforoushzadeh MA, Sayareh S, Hejazi SH.

J Educ Health Promot. 2017 Jun 5;6:44. doi: 10.4103/jehp.jehp_118_14. eCollection 2017.

3.

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime.

Soleimanifard S, Arjmand R, Saberi S, Salehi M, Hejazi SH.

Adv Biomed Res. 2017 Mar 1;6:17. doi: 10.4103/2277-9175.201329. eCollection 2017.

4.

In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime.

Saberi S, Arjmand R, Soleimanifard S, Khamesipour A, Hosseini SM, Salehi M, Varshosaz J, Palizban AA, Hejazi SH.

Adv Biomed Res. 2016 Jul 29;5:126. doi: 10.4103/2277-9175.187000. eCollection 2016.

5.

Anti-Leishmania Activity of Osthole.

Kermani EK, Sajjadi SE, Hejazi SH, Arjmand R, Saberi S, Eskandarian AA.

Pharmacognosy Res. 2016 Mar;8(Suppl 1):S1-4. doi: 10.4103/0974-8490.178650.

6.

Surveillance of Antibiotic Consumption Point Prevalence Survey 2014: Antimicrobial Prescribing in Pediatrics Wards of 16 Iranian Hospitals.

Fahimzad A, Eydian Z, Karimi A, Shiva F, Sayyahfar S, Kahbazi M, Rahbarimanesh A, Sedighi I, Arjmand R, Soleimani G, Sanaei Dashti A, Abdinia B, Mostafavi N, Nikfar R, Abedini M, Rezaei MS, Mohammadpour A, Hashemian H, Hidari H, Ghadiri K, Entezari Heravi R.

Arch Iran Med. 2016 Mar;19(3):204-9. doi: 0161903/AIM.009.

7.

Antigenic profile of heat-killed versus thimerosal-treated Leishmania major using sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Arjmand R, Fard SS, Saberi S, Tolouei S, Khamesipour A, Hejazi SH.

Adv Biomed Res. 2015 Jun 4;4:128. doi: 10.4103/2277-9175.158068. eCollection 2015.

8.

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S.

Iran J Parasitol. 2014 Sep;9(3):423-8.

9.

Identification of Leishmania isolates from Varzaneh city, Isfahan province, Iran using nested polymerase chain reaction method.

Arjmand R, Saberi S, Tolouei S, Chizari Z, Nobari RF, Fard SS, Akbari M, Hejazi SH.

Adv Biomed Res. 2014 Aug 19;3:167. doi: 10.4103/2277-9175.139131. eCollection 2014.

10.

Serologic evidence of pertussis infection in vaccinated Iranian children.

Dashti AS, Karimi A, Arjmand R, Moghadami M, Kheirkhah T, Shiva F, Gholinejad Z, Joulaei H.

Iran J Med Sci. 2012 Dec;37(4):260-5.

11.

A child with intestinal basidiobolomycosis.

Arjmand R, Karimi A, Sanaei Dashti A, Kadivar M.

Iran J Med Sci. 2012 Jun;37(2):134-6.

Supplemental Content

Loading ...
Support Center